Tenax Therapeutics Inc (TENX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $73.77M
Last updated: Nov 17, 2026 at 11:05 AM ET
Tenax Therapeutics Inc (TENX) Competitors
The companies most similar to Tenax Therapeutics are Tenaya Therapeutics (TNYA), Tonix Pharmaceuticals Holding (TNXP) and NRX Pharmaceuticals (NRXP). By market cap, Tenax Therapeutics ranks 7th of the 13 companies on this page; LENZ Therapeutics (LENZ) is the largest at $129.77M.
Peer Comparison
TENX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Tenax Therapeutics (TENX) | $73.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tonix Pharmaceuticals Holding Corp (TNXP) | $58.49M | N/A | 1.2x | 0.0% | N/A | 423.8% | 0.00% |
| NRX Pharmaceuticals Inc (NRXP) | $95.58M | N/A | 23.8x | 0.0% | N/A | 0.0% | 0.00% |
| Neumora Therapeutics, Inc. (NMRA) | $80.59M | N/A | N/A | 0.0% | -260.5% | 0.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| vTv Therapeutics Inc (VTVT) | $78.99M | N/A | N/A | -20.8% | N/A | 0.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Actinium Pharmaceuticals Inc (ATNM) | $51.56M | 4.1x | 1.3x | 32.2% | N/A | -100.0% | 0.00% |
| Anixa Biosciences Inc (ANIX) | $91.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Rein Therapeutics Inc (RNTX) | $47.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| LENZ Therapeutics Inc (LENZ) | $129.77M | N/A | 9.7x | 0.0% | N/A | -72.9% | 0.00% |
| Peer median | $68.74M | 4.1x | 2.0x | 0.0% | -260.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Tenax Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Tonix Pharmaceuticals Holding Corp (TNXP) | Tonix Pharmaceuticals Holding Corp. The company is headquartered in Chatham, New Jersey. | TNXP competitors |
| NRX Pharmaceuticals Inc (NRXP) | NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company... | NRXP competitors |
| Neumora Therapeutics, Inc. (NMRA) | Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases... | NMRA competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| vTv Therapeutics Inc (VTVT) | vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet... | VTVT competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Actinium Pharmaceuticals Inc (ATNM) | Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation... | ATNM competitors |
| Anixa Biosciences Inc (ANIX) | Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. | ANIX competitors |
| Rein Therapeutics Inc (RNTX) | Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders... | RNTX competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| LENZ Therapeutics Inc (LENZ) | LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders... | LENZ competitors |
Frequently Asked Questions About TENX
Who are Tenax Therapeutics' main competitors?
The companies most similar to Tenax Therapeutics include Tenaya Therapeutics (TNYA), Tonix Pharmaceuticals Holding (TNXP), NRX Pharmaceuticals (NRXP), Neumora Therapeutics (NMRA) and Gain Therapeutics (GANX), listed from the closest match.
Who is Tenax Therapeutics' biggest competitor?
LENZ Therapeutics (LENZ) is the largest of the similar companies at $129.77M; Tenaya Therapeutics (TNYA) is the closest match by business profile, size, sector and industry.
How does TENX stock compare with its competitors?
TENX's net margin is 0.0% against a peer median of 0.0%.
Which of Tenax Therapeutics' competitors pays a higher dividend?
Tenax Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Tenax Therapeutics bigger than its competitors?
No. Tenax Therapeutics is 7th by market cap among the 13 companies on this page; the largest is LENZ Therapeutics (LENZ) at $129.77M.
TENX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors